Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart
Bin Zhou, … , Sergei G. Tevosian, William T. Pu
Bin Zhou, … , Sergei G. Tevosian, William T. Pu
Published May 1, 2009
Citation Information: J Clin Invest. 2009;119(6):1462-1476. https://doi.org/10.1172/JCI38723.
View: Text | PDF
Research Article Cardiology

Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart

  • Text
  • PDF
Abstract

Aberrant transcriptional regulation contributes to the pathogenesis of both congenital and adult forms of heart disease. While the transcriptional regulator friend of Gata 2 (FOG2) is known to be essential for heart morphogenesis and coronary development, its tissue-specific function has not been previously investigated. Additionally, little is known about the role of FOG2 in the adult heart. Here we used spatiotemporally regulated inactivation of Fog2 to delineate its function in both the embryonic and adult mouse heart. Early cardiomyocyte-restricted loss of Fog2 recapitulated the cardiac and coronary defects of the Fog2 germline murine knockouts. Later cardiomyocyte-restricted loss of Fog2 (Fog2MC) did not result in defects in cardiac structure or coronary vessel formation. However, Fog2MC adult mice had severely depressed ventricular function and died at 8–14 weeks. Fog2MC adult hearts displayed a paucity of coronary vessels, associated with myocardial hypoxia, increased cardiomyocyte apoptosis, and cardiac fibrosis. Induced inactivation of Fog2 in the adult mouse heart resulted in similar phenotypes, as did ablation of the FOG2 interaction with the transcription factor GATA4. Loss of the FOG2 or FOG2-GATA4 interaction altered the expression of a panel of angiogenesis-related genes. Collectively, our data indicate that FOG2 regulates adult heart function and coronary angiogenesis.

Authors

Bin Zhou, Qing Ma, Sek Won Kong, Yongwu Hu, Patrick H. Campbell, Francis X. McGowan, Kate G. Ackerman, Bingruo Wu, Bin Zhou, Sergei G. Tevosian, William T. Pu

×

Figure 1

Temporal tissue-restricted inactivation of Fog2.

Options: View larger image (or click on image) Download as PowerPoint
Temporal tissue-restricted inactivation of Fog2.
   
(A) Whole-mount X-g...
(A) Whole-mount X-gal staining of E9.5–E11.5 Fog2Lz/+ embryos. (B) Section of an E10.5 Fog2Lz/+ embryo stained with X-gal. Fog2 was expressed in cardiomyocytes (1, red arrows), epicardial cells (black arrows), endocardial cells (green arrows), and AV cushion mesenchymal cells (2, asterisk). (C and D) Immunohistochemical staining for FOG2 (red) and NKX2-5 (green; cardiomyocyte marker). At E9.5, FOG2 was readily detected in Fog2fl/– control cardiomyocytes (yellow arrowheads). In littermate Fog2NK heart, FOG2 immunoreactivity was lost in myocardium (My, green arrowheads) but remained in endocardial cushion (Cu, white arrowheads). Staining of Fog2NKRosa26fsLz/+ for Cre-activated β-gal expression (red) confirmed recombination in cardiomyocytes at E9.5 (green; white arrows). (E and F) In Fog2MCRosafsLz/+ and Fog2fl/– hearts, at E9.5 FOG2 (red) was expressed in cardiomyocytes (green NKX2-5 staining; yellow arrowheads). At this stage, the Myh6-Cre transgene has not yet catalyzed efficient recombination, as indicated by lack of robust β-gal expression from the Cre-activated reporter (green arrows). (G and H) At E12.5, FOG2 immunoreactivity was readily detected in Fog2fl/– control cardiomyocytes (yellow arrowheads) but not Fog2MC mutant cardiomyocytes (green arrowheads). The Cre-activated reporter robustly expressed β-gal in cardiomyocytes at E12.5 (white arrows). Scale bar: 50 μm. All box regions indicate the magnified figures on right sides (C–H).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts